GB9721352D0 - Resistance modifying agent - Google Patents

Resistance modifying agent

Info

Publication number
GB9721352D0
GB9721352D0 GBGB9721352.4A GB9721352A GB9721352D0 GB 9721352 D0 GB9721352 D0 GB 9721352D0 GB 9721352 A GB9721352 A GB 9721352A GB 9721352 D0 GB9721352 D0 GB 9721352D0
Authority
GB
United Kingdom
Prior art keywords
modifying agent
resistance modifying
resistance
agent
modifying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9721352.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medinnova SF
Original Assignee
Medinnova SF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medinnova SF filed Critical Medinnova SF
Priority to GBGB9721352.4A priority Critical patent/GB9721352D0/en
Publication of GB9721352D0 publication Critical patent/GB9721352D0/en
Priority to AU93583/98A priority patent/AU9358398A/en
Priority to PCT/GB1998/003012 priority patent/WO1999017757A1/en
Ceased legal-status Critical Current

Links

GBGB9721352.4A 1997-10-08 1997-10-08 Resistance modifying agent Ceased GB9721352D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9721352.4A GB9721352D0 (en) 1997-10-08 1997-10-08 Resistance modifying agent
AU93583/98A AU9358398A (en) 1997-10-08 1998-10-08 Use of p-glycoprotein (pgp) inhibitors in the treatment of cancer
PCT/GB1998/003012 WO1999017757A1 (en) 1997-10-08 1998-10-08 USE OF P-GLYCOPROTEIN (Pgp) INHIBITORS IN THE TREATMENT OF CANCER

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9721352.4A GB9721352D0 (en) 1997-10-08 1997-10-08 Resistance modifying agent

Publications (1)

Publication Number Publication Date
GB9721352D0 true GB9721352D0 (en) 1997-12-10

Family

ID=10820239

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9721352.4A Ceased GB9721352D0 (en) 1997-10-08 1997-10-08 Resistance modifying agent

Country Status (3)

Country Link
AU (1) AU9358398A (en)
GB (1) GB9721352D0 (en)
WO (1) WO1999017757A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002005818A2 (en) * 2000-07-18 2002-01-24 Eli Lilly And Company Novel method of use of multidrug resistance modulators
GB0113663D0 (en) * 2001-06-05 2001-07-25 Novartis Ag Use of organic compounds
KR100503889B1 (en) * 2002-07-20 2005-07-26 한국과학기술연구원 Absorption enhancer of anticancer drugs
CN111718296B (en) * 2019-03-20 2023-10-20 复旦大学 Application of CD 133-targeted small molecular compound LY335979 in preparation of antitumor drugs

Also Published As

Publication number Publication date
AU9358398A (en) 1999-04-27
WO1999017757A1 (en) 1999-04-15

Similar Documents

Publication Publication Date Title
GB2325840B (en) Heater-sensor complex
EP1008352A4 (en) Brain-protective agent
GB9727518D0 (en) Use
EP0968655A4 (en) Spread
ZA987483B (en) Contrast agent
GB9721352D0 (en) Resistance modifying agent
EP0935965A4 (en) Antipylori agent
MD823F1 (en) Antimutagenous agent
PL324932A1 (en) Mould-killing agent
IL136525A0 (en) Agents
CA82746S (en) Handleset
CA79884S (en) Moniitor
CA80851S (en) Thermomter
CA80915S (en) Elbow-rest
CA81694S (en) Tape-rule
CA82218S (en) Sports-glasses
CA82333S (en) Remorque
CA82745S (en) Handleset
CA82748S (en) Handleset
GB9709088D0 (en) Contrast agents
GB9706063D0 (en) Contrast agents
TW348544U (en) Swimmed glove
IL122280A0 (en) Anti-obesity agent
GB9703532D0 (en) Anti-microbial agent
HUP9903411A3 (en) Wood-protecting agent

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)